A phase II trial of Novaferon for Locally Advanced Pancreatic Adenocarcinoma

Trial Profile

A phase II trial of Novaferon for Locally Advanced Pancreatic Adenocarcinoma

Suspended
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Novaferon (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2016 Status changed from recruiting to suspended.
    • 21 May 2012 Planned end date changed from 1 Apr 2011 to 31 Jul 2011 as reported by Chinese Clinical Trial Register.
    • 17 Sep 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top